Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Morihiro Okada
Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus
Journal of Pharmaceutical Health Care and Sciences
Mutation of P53 in Recurrent Hepatocellular Carcinoma and Its Association With the Expression of ZBP-89
American Journal of Pathology
Forensic Medicine
Pathology
Related publications
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pdb64 - Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Quality of Life of Patients With Type 2 Diabetes Mellitus in Mosul
Annals of the College of Medicine, Mosul
A European, Multicentre, Retrospective, Non-Interventional Study (EU-TREAT) of the Effectiveness of Insulin Degludec After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Use of Ultra-Long-Acting Insulin Analogue Degludec in Type 1 Diabetes Mellitus in Clinical Practice: The Influence on Quality of Life and Satisfaction With Treatment
Almanac of Clinical Medicine
Clinical Study of Treatment Switching From Premixed Insulin to Basal Insulin Combined With Oral Hypoglycemic Drugs in Patients With Type 2 Diabetes
Diabetology and Metabolic Syndrome
Internal Medicine
Endocrinology
Metabolism
Diabetes
An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin
Journal of Medical Economics
Health Policy
Characteristics of Patients, Self-Efficacy and Quality of Life Among Patients With Type 2 Diabetes Mellitus
Jurnal Keperawatan Padjadjaran
